Azacitidine
- Strength
- 100 mg/1
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Nucleoside Metabolic Inhibitor
Sandoz Inc
azacitidine for
Listed by Pilnova Pharma Inc
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous, Subcutaneous |
| Drug class | Nucleoside Metabolic Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 83774-102 |
| FDA application | ANDA207518 |
| RxNorm concept | 485246 |
| Package sizes listed | 1 |
| Marketed since | March 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Sandoz Inc
Hikma Pharmaceuticals USA Inc.
BluePoint Laboratories
BluePoint Laboratories
Armas Pharmaceuticals Inc.
Apotex Corp
BluePoint Laboratories.
MSN LABORATORIES PRIVATE LIMITED
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.